Description
💊 AMANTADINE 193 mg EXTENDED-RELEASE CAPSULE
Targeted Neurological Therapy with 24-Hour Symptom Control
COMPOSITION:
-
Amantadine Hydrochloride 193 mg
(Extended-release capsule for oral administration, once daily)
WHAT IS AMANTADINE 193 mg?
Amantadine 193 mg extended-release is a dopaminergic agent and NMDA receptor antagonist used to treat specific symptoms in Parkinson’s disease (PD) and drug-induced extrapyramidal reactions. This dosage form delivers sustained symptom relief with a single daily dose, improving compliance and reducing fluctuation in drug levels.
It is especially effective for Parkinson’s disease-related dyskinesia, making it a valuable adjunct to levodopa therapy in advanced-stage PD.
MECHANISM OF ACTION:
Amantadine acts via dual central mechanisms:
-
Dopaminergic Modulation
-
Increases dopamine release and inhibits dopamine reuptake in the brain.
-
Alleviates symptoms such as rigidity, tremors, and bradykinesia in Parkinson’s disease.
-
-
NMDA Receptor Antagonism
-
Inhibits N-methyl-D-aspartate (NMDA) receptors, reducing glutamatergic overactivity.
-
Helps manage levodopa-induced dyskinesia by regulating excitatory neurotransmission.
-
INDICATIONS:
-
Parkinson’s disease (as monotherapy in early stages or adjunct in advanced PD)
-
Treatment of levodopa-induced dyskinesia
-
Drug-induced extrapyramidal symptoms (EPS), especially from antipsychotics
-
Fatigue in multiple sclerosis (off-label)
-
Post-viral fatigue syndromes (investigational use)
DOSAGE & ADMINISTRATION:
-
Usual adult dose:
-
193 mg once daily, preferably in the morning
-
-
May be titrated depending on clinical response and tolerability
-
Swallow capsule whole—do not crush, chew, or open
-
Renal function should be assessed before initiating treatment
KEY BENEFITS:
✅ Once-daily dosing for patient convenience
✅ Controls both Parkinsonian symptoms and dyskinesia
✅ Extended-release profile ensures stable drug levels
✅ Can reduce need for higher levodopa doses
✅ May improve motor function, fatigue, and daily activity
PRECAUTIONS:
-
Caution in patients with:
-
Renal impairment
-
History of seizures
-
Congestive heart failure
-
Psychiatric disorders (hallucinations, confusion)
-
-
Avoid sudden discontinuation—taper gradually
-
May cause sleep disturbances if taken too late in the day
POSSIBLE SIDE EFFECTS:
-
Common: Dry mouth, dizziness, insomnia, constipation, nausea
-
Occasional: Orthostatic hypotension, anxiety, blurred vision
-
Rare:
-
Livedo reticularis (mottled skin discoloration)
-
Hallucinations or confusion in elderly
-
Peripheral edema
-
CONTRAINDICATIONS:
-
Hypersensitivity to amantadine
-
Untreated narrow-angle glaucoma
-
Severe renal dysfunction (without dose adjustment)
STORAGE CONDITIONS:
-
Store at 15–30°C, protected from light and moisture
-
Keep in original container and out of reach of children
DISCLAIMER:
This summary is intended for informational and educational purposes only. Always consult a qualified healthcare provider before starting or stopping any medication. Proper monitoring is essential for safe use, especially in elderly or renally impaired patients.
AMLOKIND AT TABLET